Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Bladder Carcinoma Infiltrating the Muscle of the Bladder Wall”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)WithdrawnNCT06290687
What this trial is testing

Partial Cystectomy & Extended Pelvic Lymph Node Dissection With SOC Perioperative Systemic Therapy

Who this might be right for
Malignant Neoplasm of BladderMuscle Invasive Bladder Carcinoma
Case Comprehensive Cancer Center
Not applicableStudy completedNCT04598724
What this trial is testing

Addressing Barriers to Palliative Care Use in Bladder Cancer

Who this might be right for
Muscle-Invasive Bladder CarcinomaBladder Cancer Stage IIBladder Cancer Stage III+1 more
H. Lee Moffitt Cancer Center and Research Institute 54
Testing effectiveness (Phase 2)Looking for participantsNCT06470282
What this trial is testing

Enfortumab Vedotin and Pembrolizumab Combined With Radiotherapy in Muscle Invasive Bladder Cancer

Who this might be right for
Bladder CancerMuscle-Invasive Bladder CarcinomaStage II Bladder Cancer AJCC v8+1 more
University of California, San Francisco 47
Very early researchWithdrawnNCT05395260
What this trial is testing

FL- 101 Study in Non-Metastatic MIBC

Who this might be right for
Muscle Invasive Bladder Carcinoma
Flame Biosciences
Early research (Phase 1)Study completedNCT04610671
What this trial is testing

Study of CG0070 Combined With Nivolumab in Cisplatin Ineligible Patients With MIBC

Who this might be right for
Muscle-Invasive Bladder CarcinomaBladder Cancer
H. Lee Moffitt Cancer Center and Research Institute 21
Early research (Phase 1)Looking for participantsNCT05833867
What this trial is testing

Adaptive RADiation Therapy With Concurrent Sacituzumab Govitecan (SG) for Muscle Invasive Bladder Cancer

Who this might be right for
Localized Muscle Invasive Bladder Urothelial CarcinomaMuscle-Invasive Bladder Carcinoma
Shilpa Gupta, MD 20
Testing effectiveness (Phase 2)WithdrawnNCT05564416
What this trial is testing

Testing Anti-Cancer Drugs Erdafitinib With or Without Atezolizumab in Patients With Localized Bladder Cancer Not Able to Receive Cisplatin Chemotherapy, NERA Trial

Who this might be right for
Bladder CarcinomaBladder Urothelial CarcinomaMuscle Invasive Bladder Carcinoma+5 more
National Cancer Institute (NCI)
Early research (Phase 1)Not Yet RecruitingNCT07725796
What this trial is testing

Dose-escalation Study of UGN-501 Administered Intravesically in Adult Participants With Recurrent NMIBC

Who this might be right for
Bladder (Urothelial, Transitional Cell) CancerNMIBCUrothelial Carcinoma Bladder+5 more
UroGen Pharma, Inc., a subsidiary of UroGen Pharma Ltd. 30
Early research (Phase 1)Active Not RecruitingNCT05483868
What this trial is testing

A Phase 1, Open-label Trial of Belzupacap Sarotalocan (AU-011) in Bladder Cancer

Who this might be right for
Non-muscle-invasive Bladder CancerNMIBCNon-Muscle Invasive Bladder Carcinoma+3 more
Aura Biosciences 55
Testing effectiveness (Phase 2)Looking for participantsNCT06571708
What this trial is testing

Gemcitabine/Cisplatin Plus Cemiplimab With or Without Fianlimab in Localized Muscle-invasive Bladder Cancer (NeoSTOP-IT)

Who this might be right for
Bladder CancerMuscle-Invasive Bladder Carcinoma
Columbia University 36
Not applicableLooking for participantsNCT06537960
What this trial is testing

Interest of Late Images for the Assessment of Extensions in 18FGD PET-CT of Muscle-Invasive Bladder Cancers

Who this might be right for
Muscle-Invasive Bladder CarcinomaBladder Cancer
Hopital Foch 66
Not applicableEnded earlyNCT05221827
What this trial is testing

Clinical Performance Evaluation of the C2i-Test

Who this might be right for
Muscle-Invasive Bladder Carcinoma
C2i Genomics 3
Testing effectiveness (Phase 2)Study completedNCT02365818
What this trial is testing

Safety and Efficacy of CG0070 Oncolytic Virus Regimen for High Grade NMIBC After BCG Failure

Who this might be right for
Bladder Cancer
CG Oncology, Inc. 66
Not applicableUnknownNCT05767528
What this trial is testing

Clinical Study of Neoadjuvant Therapy Outcome Prediction of Muscle-invasive Bladder Cancer Based on PTC Drug Sensitivity Detection

Who this might be right for
Muscle-Invasive Bladder Carcinoma
Chinese PLA General Hospital 40
Not applicableLooking for participantsNCT06170177
What this trial is testing

Study on the Quality of Life and Pathological State in Patients Who Underwent Radical Cystectomy

Who this might be right for
Muscle-Invasive Bladder CarcinomaMuscle Invasive Bladder Urothelial CarcinomaBladder Cancer TNM Staging+14 more
IRCCS San Raffaele 4,000
Testing effectiveness (Phase 2)UnknownNCT06074484
What this trial is testing

RC48-ADC Combined With AK104 For Perioperative Treatment of Muscle-Invasive Bladder Cancer

Who this might be right for
Muscle Invasive Bladder Carcinoma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 36
Large-scale testing (Phase 3)Active Not RecruitingNCT03775265
What this trial is testing

Chemoradiotherapy With or Without Atezolizumab in Treating Patients With Localized Muscle Invasive Bladder Cancer

Who this might be right for
Bladder Urothelial CarcinomaMuscle Invasive Bladder CarcinomaStage II Bladder Cancer AJCC v8+1 more
National Cancer Institute (NCI) 475
Not applicableNot Yet RecruitingNCT07817173
What this trial is testing

Feasibility of HISA During TURBT for NMIBC

Who this might be right for
Bladder CancerBladder (Urothelial, Transitional Cell) Cancer Resectable (Pre-Cystectomy)Non-muscle Invasive Bladder Cancer (NMIBC)+6 more
CAMC Health System 40
Testing effectiveness (Phase 2)UnknownNCT04909775
What this trial is testing

Chemotherapy Combined With Tislelizumab as Bladder Sparing Option for Patients With Muscle Invasive Bladder Cancer

Who this might be right for
Muscle-Invasive Bladder Carcinoma
Ruijin Hospital 40
Not applicableLooking for participantsNCT07234968
What this trial is testing

Clinical Trial to Evaluate Post-Operative Outcomes of Ureteral Stent vs Ureteral Stent Free Radical Cystectomy

Who this might be right for
Bladder CancerMuscle-Invasive Bladder CarcinomaUrothelial Carcinoma+3 more
Thomas Jefferson University 70
Next Page